|
Clinical and genetic predictors of prognosis in myelodysplastic syndromes
|
Jun 2014
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
|
Mar 2021
|
Leukemia
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia
|
Jan 2017
|
Eur Rev Med Pharmacol Sci
|
aplastic anemia
|
|
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
|
Dec 2018
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy
|
Jul 2018
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
|
Clinical decision‐making and treatment of myelodysplastic syndromes
|
Oct 2023
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
|
Sep 2016
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes
|
Jul 2017
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.
|
Jan 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki
|
Oct 2016
|
Cancer Sci.
|
myelodysplastic syndromes (MDS)
|
